As of Oct 02
| +0.20 / +0.26%|
The 5 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 157.00, with a high estimate of 285.00 and a low estimate of 94.00. The median estimate represents a +104.16% increase from the last price of 76.90.
The current consensus among 6 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.